130 related articles for article (PubMed ID: 10726021)
1. Effects of ticlopidine or ticlopidine plus aspirin on platelet aggregation and ATP release in normal volunteers: why aspirin improves ticlopidine antiplatelet activity.
Altman R; Scazziota A; Rouvier J; Gonzalez C
Clin Appl Thromb Hemost; 1999 Oct; 5(4):243-6. PubMed ID: 10726021
[TBL] [Abstract][Full Text] [Related]
2. Abciximab treatment in vitro after aspirin treatment in vivo has additive effects on platelet aggregation, ATP release, and P-selectin expression.
Scazziota A; Altman R; Rouvier J; Gonzalez C; Ahmed Z; Jeske WP; Walenga JM; Fareed J
Thromb Res; 2000 Dec; 100(6):479-88. PubMed ID: 11152927
[TBL] [Abstract][Full Text] [Related]
3. [Clinical evaluation of platelet antagonists on the ex vivo inhibitory effects of platelet aggregation].
Sakata T; Kobayashi K; Katayama Y; Takada T; Matsuyama T
Rinsho Byori; 1991 Mar; 39(3):315-20. PubMed ID: 2051607
[TBL] [Abstract][Full Text] [Related]
4. The lack of augmentation by aspirin of inhibition of platelet reactivity by ticlopidine.
Farrell TP; Hayes KB; Sobel BE; Schneider DJ
Am J Cardiol; 1999 Mar; 83(5):770-4. PubMed ID: 10080435
[TBL] [Abstract][Full Text] [Related]
5. Effect of diltiazem and low-dose aspirin on platelet aggregation and ATP release induced by paired agonists.
Zucker ML; Budd SE; Dollar LE; Chernoff SB; Altman R
Thromb Haemost; 1993 Aug; 70(2):332-5. PubMed ID: 8236144
[TBL] [Abstract][Full Text] [Related]
6. The antiaggregating and antithrombotic activity of ticlopidine is potentiated by aspirin in the rat.
Herbert JM; Bernat A; Samama M; Maffrand JP
Thromb Haemost; 1996 Jul; 76(1):94-8. PubMed ID: 8819259
[TBL] [Abstract][Full Text] [Related]
7. [Antiplatelet effects of combined therapy with ticlopidine and low doses of aspirin on patients with ischemic cardiopathy].
Davì G; Catalano I; Spatola A; Alaimo P; Notarbartolo A; Cerbone AM; Strano A
Cardiologia; 1989 Jan; 34(1):69-71. PubMed ID: 2720715
[TBL] [Abstract][Full Text] [Related]
8. Effects of ticlopidine on von Willebrand factor-mediated shear-induced platelet activation and aggregation.
Goto S; Tamura N; Sakakibara M; Ikeda Y; Handa S
Platelets; 2001 Nov; 12(7):406-14. PubMed ID: 11674857
[TBL] [Abstract][Full Text] [Related]
9. The efficacy and potency of antiplatelet activity of ticlopidine is increased by aspirin.
Splawinska B; Kuzniar J; Malinga K; Mazurek AP; Splawinski J
Int J Clin Pharmacol Ther; 1996 Aug; 34(8):352-6. PubMed ID: 8864799
[TBL] [Abstract][Full Text] [Related]
10. Effects of aspirin on platelet aggregation in smokers and nonsmokers.
Chant C; Fagan SC; Aurora SK; Gidal BE; Joseph R
Ann Pharmacother; 1997 Mar; 31(3):290-3. PubMed ID: 9066933
[TBL] [Abstract][Full Text] [Related]
11. Effects of combination therapy with low-dose aspirin and warfarin on platelet functions after heart valve replacement.
Kobune K; Inoue M; Morikawa M; Tsuboi M; Takanami Y; Iwane Y; Kudo T
Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):153-65. PubMed ID: 1811279
[TBL] [Abstract][Full Text] [Related]
12. Comparison of antiplatelet effects of aspirin, ticlopidine, or their combination after stent implantation.
Rupprecht HJ; Darius H; Borkowski U; Voigtländer T; Nowak B; Genth S; Meyer J
Circulation; 1998 Mar; 97(11):1046-52. PubMed ID: 9531251
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy with low-dose aspirin and ticlopidine in cerebral ischemia.
Uchiyama S; Sone R; Nagayama T; Shibagaki Y; Kobayashi I; Maruyama S; Kusakabe K
Stroke; 1989 Dec; 20(12):1643-7. PubMed ID: 2531943
[TBL] [Abstract][Full Text] [Related]
14. Differential impacts of CYP2C19 gene polymorphisms on the antiplatelet effects of clopidogrel and ticlopidine.
Maeda A; Ando H; Asai T; Ishiguro H; Umemoto N; Ohta M; Morishima M; Sumida A; Kobayashi T; Hosohata K; Ushijima K; Fujimura A
Clin Pharmacol Ther; 2011 Feb; 89(2):229-33. PubMed ID: 21178986
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of antiplatelet effects of a modified protocol by platelet aggregation in patients undergoing "one-stop" hybrid coronary revascularization.
Gao P; Xiong H; Zheng Z; Li L; Gao R; Hu SS
Platelets; 2010; 21(3):183-90. PubMed ID: 20201634
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of platelet aggregation by aspirin progressively decreases in long-term treated patients.
Pulcinelli FM; Pignatelli P; Celestini A; Riondino S; Gazzaniga PP; Violi F
J Am Coll Cardiol; 2004 Mar; 43(6):979-84. PubMed ID: 15028353
[TBL] [Abstract][Full Text] [Related]
17. Association of recurrent cerebral infarction with adenosine diphosphate- and collagen-induced platelet aggregation in patients treated with ticlopidine and/or aspirin.
Abumiya T; Houkin K
J Stroke Cerebrovasc Dis; 2011; 20(4):319-23. PubMed ID: 20634093
[TBL] [Abstract][Full Text] [Related]
18. The effect of antiplatelet drugs, heparin, and preanalytical variables on platelet function detected by the platelet function analyzer (PFA-100).
Kottke-Marchant K; Powers JB; Brooks L; Kundu S; Christie DJ
Clin Appl Thromb Hemost; 1999 Apr; 5(2):122-30. PubMed ID: 10725993
[TBL] [Abstract][Full Text] [Related]
19. The effect of clopidogrel, aspirin and both antiplatelet drugs on platelet function in patients with peripheral arterial disease.
Jagroop IA; Matsagas MI; Geroulakos G; Mikhailidis DP
Platelets; 2004 Mar; 15(2):117-25. PubMed ID: 15154604
[TBL] [Abstract][Full Text] [Related]
20. Cilostazol could ameliorate platelet responsiveness to clopidogrel in patients undergoing primary percutaneous coronary intervention.
Kim JY; Lee K; Shin M; Ahn M; Choe H; Yoo BS; Yoon J; Choe KH; Lee SH
Circ J; 2007 Dec; 71(12):1867-72. PubMed ID: 18037738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
